Goldman Sachs’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Goldman Sachs’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-451,468	Closed	-$4.52M	–	6604
2022 Q3	$4.52M	Sell	451,468 -10,210	-2%	-$102K	﹤0.01%	3221
2022 Q2	$4.57M	Buy	461,678 +86,497	+23%	+$854K	﹤0.01%	3218
2022 Q1	$3.7M	Buy	375,181 +134,421	+56%	+$1.32M	﹤0.01%	3631
2021 Q4	$2.36M	Sell	240,760 -44,433	-16%	-$438K	﹤0.01%	4117
2021 Q3	$2.8M	Sell	285,193 -117,999	-29%	-$1.16M	﹤0.01%	3876
2021 Q2	$3.99M	Hold	403,192	–	–	﹤0.01%	3549
2021 Q1	$4.14M	Buy	+403,192	New	+$4.48M	﹤0.01%	3311

Goldman Sachs's LUXA Position: Q4 2022 in Review

Goldman Sachs sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 451,468 shares — an estimated $4.52M sold.

Goldman Sachs first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $4.57M in Q2 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Goldman Sachs reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 451,468 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $4.52M.
Goldman Sachs first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Goldman Sachs's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $4.57M in Q2 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.